Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 308

1.

Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers.

Kordowski F, Kolarova J, Schafmayer C, Buch S, Goldmann T, Marwitz S, Kugler C, Scheufele S, Gassling V, Németh CG, Brosch M, Hampe J, Lucius R, Röder C, Kalthoff H, Siebert R, Ammerpohl O, Reiss K.

BMC Cancer. 2018 Aug 6;18(1):796. doi: 10.1186/s12885-018-4701-2.

2.

Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.

Galamb O, Kalmár A, Barták BK, Patai ÁV, Leiszter K, Péterfia B, Wichmann B, Valcz G, Veres G, Tulassay Z, Molnár B.

World J Gastroenterol. 2016 Dec 21;22(47):10325-10340. doi: 10.3748/wjg.v22.i47.10325.

3.

TRH site-specific methylation in oral and oropharyngeal squamous cell carcinoma.

Puttipanyalears C, Arayataweegool A, Chalertpet K, Rattanachayoto P, Mahattanasakul P, Tangjaturonsasme N, Kerekhanjanarong V, Mutirangura A, Kitkumthorn N.

BMC Cancer. 2018 Aug 6;18(1):786. doi: 10.1186/s12885-018-4706-x.

4.

Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.

Basu B, Chakraborty J, Chandra A, Katarkar A, Baldevbhai JRK, Dhar Chowdhury D, Ray JG, Chaudhuri K, Chatterjee R.

Clin Epigenetics. 2017 Feb 3;9:13. doi: 10.1186/s13148-017-0314-x. eCollection 2017.

5.

Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations.

Kim YH, Lee HC, Kim SY, Yeom YI, Ryu KJ, Min BH, Kim DH, Son HJ, Rhee PL, Kim JJ, Rhee JC, Kim HC, Chun HK, Grady WM, Kim YS.

Ann Surg Oncol. 2011 Aug;18(8):2338-47. doi: 10.1245/s10434-011-1573-y. Epub 2011 Feb 5.

6.

Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis.

Yan H, He J, Guan Q, Cai H, Zhang L, Zheng W, Qi L, Zhang S, Liu H, Li H, Zhao W, Yang S, Guo Z.

Oncotarget. 2017 Jul 18;8(29):47356-47364. doi: 10.18632/oncotarget.17647.

7.

Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.

Kuhmann C, Li C, Kloor M, Salou M, Weigel C, Schmidt CR, Ng LW, Tsui WW, Leung SY, Yuen ST, Becker N, Weichenhan D, Plass C, Schmezer P, Chan TL, Popanda O.

Hum Mol Genet. 2014 Apr 15;23(8):2043-54. doi: 10.1093/hmg/ddt599. Epub 2013 Nov 26.

PMID:
24282031
8.

Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.

Lin PC, Lin JK, Lin CH, Lin HH, Yang SH, Jiang JK, Chen WS, Chou CC, Tsai SF, Chang SC.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1419-27. doi: 10.1245/s10434-014-4277-2. Epub 2014 Dec 4.

PMID:
25472652
9.

Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis.

Li DJ, Feng ZC, Li XR, Hu G.

World J Gastroenterol. 2018 Nov 28;24(44):5013-5024. doi: 10.3748/wjg.v24.i44.5013.

10.

Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips.

Naumov VA, Generozov EV, Zaharjevskaya NB, Matushkina DS, Larin AK, Chernyshov SV, Alekseev MV, Shelygin YA, Govorun VM.

Epigenetics. 2013 Sep;8(9):921-34. doi: 10.4161/epi.25577. Epub 2013 Jul 17.

11.

The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging.

Ye X, Mo M, Xu S, Yang Q, Wu M, Zhang J, Chen B, Li J, Zhong Y, Huang Q, Cai C.

BMC Cancer. 2018 Oct 22;18(1):1023. doi: 10.1186/s12885-018-4921-5.

12.

LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation.

Lee CH, Pan KL, Tang YC, Tsai MH, Cheng AJ, Shen MY, Cheng YM, Huang TT, Lin P.

Oncotarget. 2015 Sep 22;6(28):25188-201. doi: 10.18632/oncotarget.4512.

13.

DNA methylome profiling identifies novel methylated genes in African American patients with colorectal neoplasia.

Ashktorab H, Daremipouran M, Goel A, Varma S, Leavitt R, Sun X, Brim H.

Epigenetics. 2014 Apr;9(4):503-12. doi: 10.4161/epi.27644. Epub 2014 Jan 17.

14.

Methylation markers of early-stage non-small cell lung cancer.

Lokk K, Vooder T, Kolde R, Välk K, Võsa U, Roosipuu R, Milani L, Fischer K, Koltsina M, Urgard E, Annilo T, Metspalu A, Tõnisson N.

PLoS One. 2012;7(6):e39813. doi: 10.1371/journal.pone.0039813. Epub 2012 Jun 29. Erratum in: PLoS One. 2017 Jan 20;12 (1):e0170833.

15.

Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.

Geybels MS, Zhao S, Wong CJ, Bibikova M, Klotzle B, Wu M, Ostrander EA, Fan JB, Feng Z, Stanford JL.

Prostate. 2015 Dec;75(16):1941-50. doi: 10.1002/pros.23093. Epub 2015 Sep 18.

16.

Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues.

Simmer F, Brinkman AB, Assenov Y, Matarese F, Kaan A, Sabatino L, Villanueva A, Huertas D, Esteller M, Lengauer T, Bock C, Colantuoni V, Altucci L, Stunnenberg HG.

Epigenetics. 2012 Dec 1;7(12):1355-67. doi: 10.4161/epi.22562. Epub 2012 Oct 18.

17.

The dynamic DNA methylation landscape of the mutL homolog 1 shore is altered by MLH1-93G>A polymorphism in normal tissues and colorectal cancer.

Savio AJ, Mrkonjic M, Lemire M, Gallinger S, Knight JA, Bapat B.

Clin Epigenetics. 2017 Mar 9;9:26. doi: 10.1186/s13148-017-0326-6. eCollection 2017.

18.

A panel of genes methylated with high frequency in colorectal cancer.

Mitchell SM, Ross JP, Drew HR, Ho T, Brown GS, Saunders NF, Duesing KR, Buckley MJ, Dunne R, Beetson I, Rand KN, McEvoy A, Thomas ML, Baker RT, Wattchow DA, Young GP, Lockett TJ, Pedersen SK, Lapointe LC, Molloy PL.

BMC Cancer. 2014 Jan 31;14:54. doi: 10.1186/1471-2407-14-54.

19.

DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.

Kalmár A, Péterfia B, Hollósi P, Galamb O, Spisák S, Wichmann B, Bodor A, Tóth K, Patai ÁV, Valcz G, Nagy ZB, Kubák V, Tulassay Z, Kovalszky I, Molnár B.

BMC Cancer. 2015 Oct 19;15:736. doi: 10.1186/s12885-015-1687-x.

20.

Promoter hypomethylation of RAR-related orphan receptor α 1 is correlated with unfavorable clinicopathological features in patients with colorectal cancer.

Kano H, Takayama T, Midorikawa Y, Nagase H.

Biosci Trends. 2016 Jul 19;10(3):202-9. doi: 10.5582/bst.2016.01097. Epub 2016 Jun 10.

Supplemental Content

Support Center